$0.10
(Market cap
$39 Mln
Revenue (TTM)
$19 Mln
P/E Ratio
51.9
P/B Ratio
3.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
29.84
-
EV/EBITDA
35.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.1
-
Face value
--
-
Shares outstanding
10,856,546
10 Years Aggregate
CFO
$-25.16 Mln
EBITDA
$-30.31 Mln
Net Profit
$-38.67 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nephros (NEPH)
| -25.0 | 19.2 | -10.3 | 58.8 | 42.7 | -14.8 | 2.4 |
|
BSE Sensex
| -11.2 | -4.2 | -9.2 | -7.4 | 6.8 | 8.7 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Nephros (NEPH)
| 232.0 | -57.2 | 199.0 | -80.3 | -31.2 | -13.8 | 94.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nephros (NEPH)
|
3.7 | 39.4 | 19.1 | 0.8 | 3.6 | 7.5 | 51.9 | 3.2 |
| 88.1 | 5,517.5 | 1,877.1 | 7.1 | 4.2 | 0.5 | 788.5 | 3.5 | |
| 286.1 | 15,430.0 | 6,058.4 | 395.5 | 11.4 | 14.2 | 39.5 | 5.8 | |
| 1.4 | 46.1 | 26.4 | -2.9 | -15.2 | -7.4 | -- | 1.2 | |
| 1.9 | 19.0 | 16.0 | -8.9 | -33.0 | -86.3 | -- | 2.2 | |
| 15.6 | 800.8 | 821.2 | 5.8 | 3.2 | 1.3 | -- | 1.3 | |
| 9.2 | 182.5 | 58.9 | -17.7 | -25.9 | -36 | -- | 4.2 | |
| 1.2 | 24.0 | 243.5 | -7.3 | 0.8 | -18.1 | -- | 0.6 | |
| 27.3 | 7,069.5 | 4,913.9 | 440.4 | 12.6 | 24.1 | 16.3 | 4.2 | |
| 0.7 | 16.6 | 5.7 | -4.3 | -65.2 | -390 | -- | 28.8 |
Shareholding Pattern
View DetailsAbout Nephros (NEPH)
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological... contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Address: 380 Lackawanna Place, South Orange, NJ, United States, 07079 Read more
-
President, CEO & Director
Mr. Robert Banks
-
President, CEO & Director
Mr. Robert Banks
-
Headquarters
South Orange, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Nephros (NEPH)
What is the current share price of Nephros Inc (NEPH) Today?
The share price of Nephros Inc (NEPH) is $3.66 (NASDAQ) as of 21-May-2026 14:24 EDT. Nephros Inc (NEPH) has given a return of 42.69% in the last 3 years.
What is the current PB & PE ratio of Nephros Inc (NEPH)?
The P/E ratio of Nephros Inc (NEPH) is 51.86 times as on 20-May-2026, a 74 premium to its peers’ median range of 29.84 times.
The P/B ratio of Nephros Inc (NEPH) is 3.18 times as on 20-May-2026, a 44 discount to its peers’ median range of 5.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
44.83
|
5.25
|
|
2024
|
209.69
|
1.81
|
|
2023
|
-23.16
|
4.36
|
|
2022
|
-1.61
|
2.13
|
|
2021
|
-14.43
|
5.07
|
What is the 52 Week High and Low of Nephros Inc (NEPH)?
The 52-week high and low of Nephros Inc (NEPH) are Rs 6.42 and Rs 2.23 as of 22-May-2026.
What is the market cap of Nephros Inc (NEPH)?
Nephros Inc (NEPH) has a market capitalisation of $ 39 Mln as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nephros Inc (NEPH)?
Before investing in Nephros Inc (NEPH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.